Probiotics for Improving Post-surgical Healing
- Conditions
- ProbioticsWound HealGastrointestinal ComplicationTooth, Impacted
- Interventions
- Procedure: Impacted tooth extraction
- Registration Number
- NCT04903925
- Lead Sponsor
- University of Pisa
- Brief Summary
A randomized, double-blind, placebo-controlled clinical trial will be performed to assess the efficacy of a probiotic containing Lactobacillus reuteri in improving post-surgical wound healing after impacted tooth extractions.
The Primary aim is to evaluate the efficacy of L. reuteri in improving post-extractive healing.
The Secondary aim is to evaluate the efficacy of L. reuteri in association with an antibiotic therapy (amoxicillin) in reducing the incidence and severity of antibiotic-associated gastro-intestinal symptoms.
- Detailed Description
Probiotics are defined by the World Health Organization as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." Human microbiome is a complex system that contributes to maintaining a good health status in humans. Broad-spectrum antibiotic therapies act against pathogen bacteria but also affect the intestinal microbiome, leading to different side effects such as abdominal pain, gastric pain, nausea, vomit and diarrhea.
The use of probiotics has been advocated as a possible means in reducing intensity and incidence of the symptoms related to antibiotic therapies. Some probiotics like Lactobacillus reuteri (L. reuteri) showed good anti-inflammatory properties and also antimicrobic action, assuming a possible role in wound healing processes.
Few studies have been conducted on the use of L. reuteri in dentistry. Twetman et al. (2018) conducted a trial to assess the efficacy of L. reuteri in improving post-surgical healing in the oral cavity after a punch biopsy, showing promising results. The authors concluded that larger trials may be useful to better clarify the role of probiotics in oral wounds healing. The only data regarding the possible role of L. reuteri in post- extractive healing comes from a pilot study (Walivara at al. 2019) that showed a reduction of the perceived swelling and of the number of disturbed-sleep nights in patients who underwent impacted-tooth extraction and assumed L. reuteri. Authors concluded that larger trials with closer follow-up visits are required to fully understand the clinical correlation.
The primary aim of the present research is to evaluate the efficacy of a probiotic containing L. reuteri in improving post-surgical healing following impacted tooth extractions and the secondary aim is to investigate its possible role in preventing or reducing gastro-intestinal side effects related to post-operative antibiotic therapy.A Randomized, double-blind, placebo-controlled clinical trial will be performed to evaluate the efficacy of L. reuteri in improving post-extractive healing.
All patients who need impacted tooth extractions at University Hospital of Pisa (Operative Unit of Odontostomatology and Oral Surgery) will be considered eligible for the study.
The number of patients to include is set to 160, divided in two experimental groups (80 patients per group). Patients who meet inclusion/exclusion criteria will be enrolled in this trial.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- need for impacted tooth extractions
- over age 18
- ability to understand and to sign an informed consent form
- allergy to penicillin
- contraindications to oral surgery
- treatment with immunosuppressive agents or immunocompromised
- treatment with amino-bisphosphonate and anti-angiogenetic medications
- irradiation to head and neck area
- uncontrolled diabetes
- renal failure
- drug and alcohol addiction
- psychiatric disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group 2 Impacted tooth extraction All patients will undergo an impacted tooth extraction; patients allocated to group 1 will receive an antibiotic therapy with amoxicillin for 6 days (2 g/day) and a placebo of the probiotic for 21 days (2 tablets/day). Group 1 Impacted tooth extraction All patients will undergo an impacted tooth extraction; patients allocated to group 1 will receive an antibiotic therapy with amoxicillin for 6 days (2 g/day) and a probiotic for 21 days (2 tablets/day).
- Primary Outcome Measures
Name Time Method Surgical wound healing 14 days after the surgery Clinical assessment of the characteristics of the surgical wound
- Secondary Outcome Measures
Name Time Method Alveolar osteitis 14 days after the surgery Presence of alveolar osteitis
Fever 14 days after the surgery Body temperature \> 37°C
Presence of pain 14 days after the surgery presence of pain assessed by VAS (0-10)
Abscess 14 days after the surgery presence of suppuration
Edema 14 days after the surgery presence and evaluation of the post-operative edema (intra-oral and extra-oral)
Trismus 14 days after the surgery reduction in mouth opening (measured in mm)
bleeding on palpation 14 days after the surgery presence of bleeding on palpation
Painkillers 7 days after the surgery Number of painkillers assumed in the first 7 days after the surgery
Difficulty in chewing 14 days after the surgery Difficulty in chewing assessed by VAS (0-10)
Difficulty in speaking 14 days after the surgery Difficulty in speaking assessed by VAS (0-10)
Abdominal distension 14 days after the surgery presence of Abdominal pain (questionnarie Y/N)
Nausea 14 days after the surgery presence of nausea (questionnarie Y/N)
Difficulty in performing oral hygiene 14 days after the surgery Difficulty in performing oral hygiene assessed by VAS (0-10)
Daily routine alterations 14 days after the surgery days of stay off work
Number of disturbed-sleep nights following the extraction 14 days after the surgery Number of disturbed-sleep nights
Vomit 14 days after the surgery presence of vomit (questionnarie Y/N)
Gastric acidity 14 days after the surgery presence of gastric acidity (questionnarie Y/N)
Loss of appetite 14 days after the surgery presence of loss of appetite (questionnarie Y/N)
Sensation of swelling 14 days after the surgery assessed by VAS (0-10)
Abdominal pain 14 days after the surgery presence of Abdominal pain (questionnarie Y/N)
Alvus variation 14 days after the surgery presence of alvus variations (questionnarie Y/N)
Acid reflux 14 days after the surgery presence of acid reflux (questionnarie Y/N)
Gastric pain 14 days after the surgery presence of gastric pain (questionnarie Y/N)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
U.O. Odontostomatologia e Chirurgia del Cavo Orale
🇮🇹Pisa, Italy